Granulomatosis With Polyangiitis Clinical Trials
3 recruiting trials for Granulomatosis With Polyangiitis. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
2
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT04871191
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
The purpose of this study is to identify the most promising therapeutic strategy for patients with granulomatosis with polyangiitis and inadequate response to standard of care...
Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 421 location
RECRUITINGPhase 3NCT06983821
Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)
The purpose of this study is to determine the safety and efficacy of a therapeutic regimen consisting of 4 weeks of glucocorticoids given with a combination of the usual induction...
Sponsor: Ottawa Hospital Research InstituteEnrolling: 362 locations
RECRUITINGPhase 2NCT06940661
Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
The purpose of this study is to evaluate the efficacy and safety of obinutuzumab to induce clinical and serological remission in patients with relapsing PR3-ANCA granulomatosis...
Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 331 location